Skip to main content
. 2017 Aug 17;108(10):2039–2044. doi: 10.1111/cas.13325

Table 3.

Acute and late adverse events for all patients (n = 35)

Acute adverse events Grade 2 (%) Grade 3 (%) Grade 4 (%)
Mucositis 15 (43) 8 (23) 0 (0)
Dermatitis 11 (31) 0 (0) 0 (0)
Conjunctivitis 5 (14) 0 (0) 0 (0)
Dysgeusia 1 (3) 0 (0) 0 (0)
Late adverse events
Mucositis 11 (31) 1 (3) 0 (0)
Dermatitis 0 (0) 0 (0) 0 (0)
Conjunctivitis 1 (3) 0 (0) 0 (0)
Dysgeusia 2 (6) 0 (0) 0 (0)
Brain necrosis 2 (6) 0 (0) 0 (0)
Cataract 0 (0) 2 (6) 0 (0)
Visual imparment 2 (6) 1 (3) 2 (6)
Trismus 3 (9) 0 (0) 0 (0)
Otitis media 5 (14) 0 (0) 0 (0)
Olfactory nerve disorder 4 (11) 0 (0) 0 (0)